Cite
HARVARD Citation
Kievit, W. et al. (2009). Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. Annals of the rheumatic diseases. 68 (6), pp. 844-849. [Online].